Evidence map›Paper›PMID 24224999›Full record

Trial reportLancet (London, England)2014

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

Nikhil V Joshi, Alex T Vesey, Michelle C Williams, Anoop S V Shah, Patrick A Calvert, Felicity H M Craighead, Su Ern Yeoh, William Wallace, Donald Salter, Alison M Fletcher and 10 more

7 registry-linked trialsOpen access · hybridAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Lancet (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 471 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
471citing papers in PubMed, 3 pooled it
62.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03233243 phase4completedstarted 2020, after this paper: background citation

Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT

Ran2020Enrolled40Registered outcomes3Posted comparisons0ConditionsAtherosclerosis, Cardiovascular Diseases, Molecular ImagingArmsRosuvastatin Oral Tablet
Open the trial in the graph
NCT02110303 phase2 / phase3completednot on this mapstarted 2015, after this paper: background citation

Dual Antiplatelet Therapy to Inhibit Coronary Atherosclerosis and Myocardial Injury in Patients With Necrotic High-Risk Coronary Plaque Disease

TypeinterventionalSponsorUniversity of EdinburghRan2015 to 2018Enrolled220ConditionsCoronary Artery DiseaseArmsTicagrelor, Placebo
NCT02278211 completednot on this mapstarted 2015, after this paper: background citation

Prediction of Recurrent Events With 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients With Myocardial Infarction

TypeobservationalSponsorUniversity of EdinburghRan2015 to 2022Enrolled995ConditionsCoronary Artery Disease, Myocardial Infarction
NCT02563964 terminatednot on this mapstarted 2017, after this paper: background citation

Characterizing Vulnerable Plaques in Non-ST-Elevation Myocardial Infarction Using 18F-NaF Positron Emission Tomography - Cardiac Magnetic Resonance Imaging: A Feasibility Study

Typeobservational_patient_registrySponsorMaastricht University Medical CenterRan2017 to 2020Enrolled10ConditionsMyocardial Infarction, Myocardial Ischemia
NCT02988531 nacompletednot on this mapstarted 2017, after this paper: background citation

Validation of PET-MRI for Cardiovascular Disease

TypeinterventionalSponsorUniversity of EdinburghRan2017 to 2017Enrolled20ConditionsMRI, PET Scan, Positron-Emission Tomography, Cardiovascular DiseaseArmsPET/MR scan
NCT03618303 nacompletednot on this mapstarted 2018, after this paper: background citation

Combined Positron Emission Tomography and Magnetic Resonance Imaging of Coronary Atherothrombosis

TypeinterventionalSponsorUniversity of EdinburghRan2018 to 2020Enrolled9ConditionsHeart Diseases, IschemicArmsPET-MRI scan
NCT03943966 nacompletednot on this mapstarted 2019, after this paper: background citation

In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer

TypeinterventionalSponsorUniversity of EdinburghRan2019 to 2021Enrolled73ConditionsThrombosis, Atherothrombosis, Myocardial Infarction, STEMIArms18F-GP1 PET CT
3 · Its place in the literature

Who cites it

471 citing papers in PubMed, 3 syntheses or guidelines pooled it, 937 citations in OpenAlex.

  1. Pooled it
  2. Vascular medicine (London, England) · 2025
    Pooled it
  3. Sodium fluoride in cardiovascular disorders: A systematic review.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Pooled it
  4. Trial
  5. Head-to-head comparison ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2024
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Cardiovascular imaging with total-body PET.The British journal of radiology · 2026
    Review
  10. Coronary artery disease imaging with total-body PET.The British journal of radiology · 2026
    Review
  11. [EJNMMI research · 2026
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Biomechanics of Plaque Rupture and Cardiovascular Calcification.Advances in experimental medicine and biology · 2026
    Review

411 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Nikhil V JoshiCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK. Electronic address: nikhil.joshi@ed.ac.uk.
Alex T VeseyCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
Michelle C WilliamsCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
Anoop S V ShahCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
Patrick A CalvertDivision of Cardiovascular Medicine, University of Cambridge, Cambridge, UK.
Felicity H M CraigheadCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
Su Ern YeohCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
William WallaceCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
Donald SalterCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
Alison M FletcherCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
Edwin J R van BeekCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
Andrew D FlapanEdinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
Neal G UrenEdinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
Miles W H BehanEdinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
Nicholas L M CrudenEdinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
Nicholas L MillsCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
Keith A A FoxCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
James H F RuddDivision of Cardiovascular Medicine, University of Cambridge, Cambridge, UK.
Marc R DweckCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
David E NewbyCentre for Cardiovascular Science, Clinical Research Imaging Centre, and Division of Pathology, University of Edinburgh, Edinburgh, UK.
University of Edinburgh · GBEdinburgh Royal Infirmary · GBUniversity of Cambridge · GB

Funding

British Heart Foundation CH/09/002British Heart Foundation FS/10/024British Heart Foundation FS/10/024/28266British Heart Foundation FS/10/026British Heart Foundation FS/10/026/28209British Heart Foundation FS/11/14/28692British Heart Foundation FS/12/29/29463British Heart Foundation FS/13/77/30488British Heart Foundation FS/14/78/31020British Heart Foundation PG/09/083/27667British Heart Foundation PG/12/8/29371Chief Scientist Office ETM/160Medical Research Council G0701127
6 · The paper itself

Abstract

backgroundThe use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used combined PET and CT to identify ruptured and high-risk atherosclerotic plaques using the radioactive tracers (18)F-sodium fluoride ((18)F-NaF) and (18)F-fluorodeoxyglucose ((18)F-FDG).

methodsIn this prospective clinical trial, patients with myocardial infarction (n=40) and stable angina (n=40) underwent (18)F-NaF and (18)F-FDG PET-CT, and invasive coronary angiography. (18)F-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic carotid disease, and with intravascular ultrasound in patients with stable angina. The primary endpoint was the comparison of (18)F-fluoride tissue-to-background ratios of culprit and non-culprit coronary plaques of patients with acute myocardial infarction.

findingsIn 37 (93%) patients with myocardial infarction, the highest coronary (18)F-NaF uptake was seen in the culprit plaque (median maximum tissue-to-background ratio: culprit 1·66 [IQR 1·40-2·25] vs highest non-culprit 1·24 [1·06-1·38], p<0·0001). By contrast, coronary (18)F-FDG uptake was commonly obscured by myocardial uptake and where discernible, there were no differences between culprit and non-culprit plaques (1·71 [1·40-2·13] vs 1·58 [1·28-2·01], p=0·34). Marked (18)F-NaF uptake occurred at the site of all carotid plaque ruptures and was associated with histological evidence of active calcification, macrophage infiltration, apoptosis, and necrosis. 18 (45%) patients with stable angina had plaques with focal (18)F-NaF uptake (maximum tissue-to-background ratio 1·90 [IQR 1·61-2·17]) that were associated with more high-risk features on intravascular ultrasound than those without uptake: positive remodelling (remodelling index 1·12 [1·09-1·19] vs 1·01 [0·94-1·06]; p=0·0004), microcalcification (73% vs 21%, p=0·002), and necrotic core (25% [21-29] vs 18% [14-22], p=0·001).

interpretation(18)F-NaF PET-CT is the first non-invasive imaging method to identify and localise ruptured and high-risk coronary plaque. Future studies are needed to establish whether this method can improve the management and treatment of patients with coronary artery disease.

fundingChief Scientist Office Scotland and British Heart Foundation.

Indexed as

Coronary AngiographyPositron-Emission TomographyTomography, X-Ray ComputedAgedAngina PectorisCarotid StenosisConfounding Factors, EpidemiologicCoronary Artery DiseaseFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedMyocardial InfarctionPlaque, AtheroscleroticProspective StudiesFluorodeoxyglucose F18RadiopharmaceuticalsSodium Fluoride

Identifiers

PMID24224999
OpenAlexW2167516026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.